Skip to main content

Market Overview

Mid-Day Market Update: BSQUARE Falls After Q4 Results; Clovis Oncology Shares Jump

Share:

Midway through trading Friday, the Dow traded down 0.95% to 32,549.79 while the NASDAQ rose 0.26% to 13,150.87. The S&P also fell, dropping 0.43% to 3,898.64.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 29,667,750 cases with around 539,690 deaths. Brazil reported over 11,780,820 COVID-19 cases with 287,490 deaths, while India confirmed a total of at least 11,514,330 cases and 159,370 deaths. In total, there were at least 121,882,440 cases of COVID-19 worldwide with more than 2,692,800 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Communication services shares rose 0.5% on Friday. Meanwhile, top gainers in the sector included comScore, Inc. (NASDAQ: SCOR), up 8%, and LiveXLive Media, Inc. (NASDAQ: LIVX), up 13%.

In trading on Friday, financial shares fell 2%.

Top Headline

FedEx Corporation (NYSE: FDX) reported better-than-expected results for its third quarter and also issued strong earnings forecast for the year.

FedEx reported quarterly earnings of $3.47 per share, missing analysts’ estimates of $3.24 per share. The company’s quarterly sales came in at $21.50 billion, versus expectations of $19.96 billion.

FedEx said it expects FY21 EPS of $17.60-$18.20, versus analysts’ estimates of $17.40.

 

Equities Trading UP

Clovis Oncology, Inc. (NASDAQ: CLVS) shares shot up 38% to $7.33 after the company announced its Rubraca significantly improves PFS versus chemotherapy in patients with later-line ovarian cancer associated with a BRCA mutation.

Shares of SenesTech, Inc. (NASDAQ: SNES) got a boost, shooting 37% to $2.30 after the company announced the conclusion of agricultural deployments of ContraPest with demonstrated, sustained success in reducing rat populations and improving operating economies in poultry settings.

Marker Therapeutics, Inc. (NASDAQ: MRKR) shares were also up, gaining 29% to $2.32 after Cantor Fitzgerald initiated coverage on the stock with an Overweight rating and announced a $6 price target. The company’s CEO Peter Hoang reported purchase of 142,857 shares, while Director John Wilson also reported purchase of 1,714,285 shares in Form 4 filing.

Check out these big movers of the day

Equities Trading DOWN

Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) shares tumbled 64% to $1.86 after the biopharmaceutical company said its lead drug candidate Tilsotolimod failed to meet the primary endpoint in a Phase 3 trial for anti-PD-1 refractory advanced melanoma. JP Morgan and HC Wainwright & Co. downgraded the stock to Neutral.

Shares of NuZee, Inc. (NASDAQ: NUZE) were down 22% to $3.98 after the company priced its underwritten public offering of units at $4.50 per unit.

BSQUARE Corporation (NASDAQ: BSQR) was down, falling 17% to $4.44 after reporting Q4 results.

Commodities

In commodity news, oil traded down 0.7% to $59.58, while gold traded up 0.1% to $1,734.70.

Silver traded down 0.6% Friday to $26.205 while copper fell 0.9% to $4.0730.

Euro zone

European shares were lower today. The eurozone’s STOXX 600 declined 1.1%, the Spanish Ibex Index fell 1.5% and the German DAX 30 dropped 1.2%. Meanwhile, the French CAC 40 fell 1.1%, London’s FTSE 100 fell 1.33% and Italy’s FTSE MIB slipped 1.1%.

Germany's producer prices rose 1.9% year-over-year in February, while construction output in Italy slipped 1.5% year-over-year in January.

 

Economics

The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET.

Check out the full economic calendar here

 

Related Articles (BSQR + CLVS)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Small Cap Global Intraday Update

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com